124 related articles for article (PubMed ID: 11849404)
1. Relevance of C-reactive protein levels in peritoneal dialysis patients.
Fine A
Kidney Int; 2002 Feb; 61(2):615-20. PubMed ID: 11849404
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and chronic Chlamydia pneumoniae infection--long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis.
Haubitz M; Brunkhorst R
Nephrol Dial Transplant; 2001 Apr; 16(4):809-15. PubMed ID: 11274279
[TBL] [Abstract][Full Text] [Related]
4. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
Pilkey RM; Morton AR; Iliescu EA
Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.
Böger CA; Götz A; Stubanus M; Banas B; Deinzer M; Krüger B; Holmer SR; Schmitz G; Riegger GA; Krämer BK
Kidney Int; 2005 Jul; 68(1):217-27. PubMed ID: 15954911
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and cardiovascular disease in peritoneal dialysis patients.
Ducloux D; Bresson-Vautrin C; Kribs M; Abdelfatah A; Chalopin JM
Kidney Int; 2002 Oct; 62(4):1417-22. PubMed ID: 12234314
[TBL] [Abstract][Full Text] [Related]
9. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
[TBL] [Abstract][Full Text] [Related]
10. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.
Bakkaloglu SA; Saygili A; Sever L; Noyan A; Akman S; Ekim M; Aksu N; Doganay B; Yildiz N; Duzova A; Soylu A; Alpay H; Sonmez F; Civilibal M; Erdem S; Kardelen F
Nephrol Dial Transplant; 2009 Nov; 24(11):3525-32. PubMed ID: 19541662
[TBL] [Abstract][Full Text] [Related]
12. A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients.
Movilli E; Feliciani A; Camerini C; Brunori G; Zubani R; Scolari F; Parrinello G; Cancarini GC
Nephron Clin Pract; 2005; 101(4):c161-7. PubMed ID: 16103720
[TBL] [Abstract][Full Text] [Related]
13. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
14. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
15. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
[TBL] [Abstract][Full Text] [Related]
16. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients.
Demirci MS; Demirci C; Ozdogan O; Kircelli F; Akcicek F; Basci A; Ok E; Ozkahya M
Nephrol Dial Transplant; 2011 May; 26(5):1708-16. PubMed ID: 20921295
[TBL] [Abstract][Full Text] [Related]
17. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients.
Chen HY; Kao TW; Huang JW; Chu TS; Wu KD
Blood Purif; 2008; 26(2):138-44. PubMed ID: 18212496
[TBL] [Abstract][Full Text] [Related]
18. High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.
Jánoskuti L; Förhécz Z; Hosszúfalusi N; Kleiber M; Walentin S; Bálint O; Duba J; Rugonfalvi-Kiss S; Romics L; Karádi I; Füst G; Prohászka Z
Eur J Clin Invest; 2005 Feb; 35(2):104-11. PubMed ID: 15667581
[TBL] [Abstract][Full Text] [Related]
19. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
20. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
